Background illustration for clinical trials search

Multiple Myeloma Clinical Trials

Browse 1,243 multiple myeloma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
New

Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Philadelphia PA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06948084

Phase2, Recruiting
New

A Phase 1 Dose-escalation and Expansion Study of In Vivo BCMA-CAR T Cell Therapy (VV169) in Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Rochester MN
Sponsor: Vyriad, Inc.

Sex: All

Age: 18+

Code: NCT07802717

Phase1, Recruiting
New

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)

for
AML (Acute Myeloid Leukemia), Multiple Myeloma Refractory
Location: Camden NJ
Sponsor: Roger Strair

Sex: All

Age: 18+

Code: NCT07771803

Early_phase1, Recruiting
New

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

for
Multiple Myeloma, Triple Negative Breast Cancer,
Location: Boston MA
Sponsor: Andrew Hantel, MD

Sex: All

Age: 18+

Code: NCT07341867

Phase1, Recruiting

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

for
Non-Hodgkin Lymphoma, Multiple Myeloma, Histiocytic Neoplasms,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05093335

Early_phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Elranatamab in R/R Multiple Myeloma

for
Refractory Multiple Myeloma, Relapse Multiple Myeloma,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06138275

Phase2, Recruiting

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: K36 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05651932

Phase1, Recruiting

Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma

for
Recurrent Multiple Myeloma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06785415

Phase1, Phase2, Recruiting

A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma

for
Multiple Myeloma
Location: Miami FL, Irvine CA
Sponsor: Hoag Memorial Hospital Presbyterian

Sex: All

Age: 21+

Code: NCT04814615

Phase2, Recruiting

The Ambient Light Multiple Myeloma Study

for
Multiple Myeloma
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 21+

Code: NCT05737732

Recruiting

Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma

for
Multiple Myeloma
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18 - 60

Code: NCT00800059

Phase1, Phase2, Recruiting

Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma, Cancer
Location: Wilmington NC, Durham NC, Chapel Hill NC, Charlotte NC,
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05145400

Phase2, Recruiting

Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities

for
Multiple Myeloma
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 21+

Code: NCT04314752

Recruiting

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

for
Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia,
Location: Nashville TN
Sponsor: University of Tennessee

Sex: All

Age: 18+

Code: NCT04663100

Recruiting

Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Norfolk VA, Greenville SC, Kettering OH, Yakima WA,
Sponsor: Cylene Pharmaceuticals

Sex: All

Age: 18+

Code: NCT01199718

Phase1, Recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

for
Neoplasms, Plasma Cell, Neoplasms by Histologic Type, Neoplasms,
Location: Atlanta GA
Sponsor: OriCell Therapeutics Co., Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06271252

Phase1, Recruiting

Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma

for
Refractory Multiple Myeloma
Location: Ottawa, Kingston, Hamilton, London, Vancouver
Sponsor: Ontario Clinical Oncology Group (OCOG)

Sex: All

Age: 18+

Code: NCT06421675

Phase2, Recruiting

CAR T-cell Therapy in Patients With Renal Dysfunction

for
Non-hodgkin Lymphoma,B Cell, Multiple Myeloma,
Location: Atlanta GA
Sponsor: Northside Hospital, Inc.

Sex: All

Age: 18+

Code: NCT05909059

Phase2, Recruiting

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Montreal, Deerfield Beach FL, Miami FL, Coral Gables FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06057402

Recruiting

Sleep Apnea in Patients With MGUS and MM

for
Multiple Myeloma,
Location: Iowa City IA
Sponsor: Michael Tomasson

Sex: All

Age: 18 - 70+

Code: NCT04114084

Recruiting